We are pleased to inform you that TIEFENBACHER GROUP is successfully on its way to becoming climate neutral by the end of 2025*.
Every year, Earth Day provides the keynote for a wide range of campaigns on the broad spectrum of environmental and climate protection for everyone to initiate and permanently implement their personal environmental agenda.
As a value-driven healthcare company, dedicated to improving the life of patients worldwide. We certainly recognise the importance of taking action to tackle the urgent climate crisis we face today. To achieve this goal, we are implementing a comprehensive sustainability strategy, which includes reducing our carbon footprint by cutting energy consumption through energy savings and efficiency measures. This is correspondingly supported by the installation of large solar panels at our production sites and the use of exclusively electric company vehicles. With these measures, we already achieved a great interim goal of reducing our emissions by 80% by January this year.
Furthermore, we also have our direct impact on our environment in mind and therefore replanted trees and added further vegetation in the course of the conversion work on our properties in order to avoid further harming nature. In addition, we also filter microplastics using a reverse osmosis drinking water facility, so that not only is clean water provided for our schoolchildren in India, but we also minimise ecological disruption at the same time.
We believe that this is not only the right thing to do for the planet but also the right thing to do for our business. Being commercially successful and operating responsibly by becoming climate neutral is how we generate sustainable returns. We look forward to sharing more updates on our progress towards this important goal in the near future.
*Scope 1 and 2 according to GHG as well as business travel and employee commuting
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDF) including highly potent drugs as well as medical devices and e-health-solutions. Our purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about our solutions for better healthcare and our in-house capabilities to develop and commercialize pharmaceutical products (including highly potent drugs) and e-health-solutions for global markets, please contact us by email at info@tiefenbacher.com or visit us on www.tiefenbachergroup.com
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets (including highly potent drugs).
For more information about our finished dosage (FDF) forms and healthcare solutions, please contact Tiefenbacher Pharmaceuticals: info@tiefenbacher.com or visit us on: www.tiefenbacher-pharmaceuticals.com
